Enabling CTA Submission In Record Time: Proven Strategies For Adenovirus Program Success

Developing adenovirus-based therapies comes with immense pressure to move fast while maintaining high scientific and quality standards. Tight deadlines and changing regulations make this a challenge.

This webinar offers a behind-the-scenes look at how one adenovirus program successfully went from concept to clinic. Experts from 3PBIOVIAN share lessons learned, common pitfalls to avoid, and practical strategies to accelerate your Clinical Trial Application (CTA) submission.

Learn how to:

• Navigate the critical stages of adenovirus manufacturing.
• Optimize your processes and quality controls for scalable, rapid, and compliant production.
• Apply real-world experience to speed up your own viral vector development timelines.

This session is for anyone in gene therapy, vaccine development, or viral vector production who needs to improve efficiency and reduce their timelines.